PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Kidney Int
; 103(1): 207-217, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-36007597
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hyperoxaluria
/
Hyperoxaluria, Primary
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Kidney Int
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United States